November25th,2020By Kelsey KaustinenGetting the lowdown on GLO2Researchers publish new data on the enzyme glyoxalase II and its role in cellular metabolism
November25th,2020By Mel J. YeatesDeveloping a cell therapy control switchNutrient-based safety switches can be applied to CAR-T, stem cell and TCR therapies
November17th,2020By Mel J. YeatesmiRagen brings in Viridian TherapeuticsThe acquisition includes clinical stage anti-IGF-1R monoclonal antibody VRDN-001, which is intended for treatment of thyroid eye disease
November16th,2020By Jeffrey BouleyDuke University and eGenesis team up on xenotransplantationPair announces research collaboration leveraging eGenesis’ genome engineering and transgenic production capabilities to conduct in-vivo testing of pancreatic islet cell xenotransplants
July15th,2020By DDN StaffAn API boostEvonik announces first stage of program to increase contract manufacturing in Germany
July15th,2020By Ilene SchneiderSEEK and ye shall findThrive’s blood test reportedly identifies multiple types of cancer
July14th,2020By DDN StaffPreventing height impairment and its complicationsQED Therapeutics doses first child in Phase 2 clinical trial of the investigational medicine infigratinib in achondroplasia
June15th,2020By DDN StaffIntabio introduces Blaze for biotherapeuticsIntabio launches their Blaze System in the hopes of accelerating biotherapeutic development
June9th,2020By DDN StaffNovel pathway for NASHCN Bio and Cambridge University identify a regulatory pathway that may be driving the problematic liver disease
June1st,2020By DDN StaffMaking a deal on ADCsTrio Pharmaceuticals and Ajinomoto enter into development collaboration